Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics.
By P. Flood-Page, A. Menzies-Gow, S. Phipps, S. Ying, A. Wangoo, M. Ludwig, N. Barnes, D. Robinson, A. Kay. Journal of Clinical Investigation, 2003
834 citations recorded by the source corpus.
Subfields: Physiology, Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/cbea08129b55390f9c607cfcccfdd6cc6ad0c80e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Physiology
In Pulmonary and Respiratory Medicine
In Surgery
Citations in the corpus
- Eosinophils: Biological Properties and Role in Health and Disease (2008, background): “The temporal association between increased inflammatory cell infiltration and increased AHR at 24 hours after allergen challenge in dual responders (Brusasco et al. 1990; Flood-Page et al. 2003b; Dorman et al. 2004a) has led to the suggestion of a causal relationship between the two.”
- Mepolizumab treatment in patients with severe eosinophilic asthma. (2014, neutral): “Worsening of asthma 29 (15) 18 (9) 13 (7)”
- A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. (2007, background): “However, the significant changes in parameters of airway remodeling seen in patients with asthma treated with mepolizumab (36, 37 ), together with effective clinical response to mepolizumab in hypereosinophilic syndromes driven by IL-5 (38‐40), would argue that tissue eosinophils are at least parti”